Epidemiologic and Molecular Relationship Between Vaccine Manufacture and Autism Spectrum Disorder Prevalence.
- Published in:
- Issues in Law & Medicine, 2015, v. 30, n. 1, p. 47
- By:
- Publication type:
- Article
Works matching DE "MMR vaccine research"
Results: 17
1
2
MMR vaccine and autism study finds no harmful association.
- Published in:
- Education Journal, 2015, n. 230, p. 17
- Publication type:
- Article
3
Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 6, p. 667, doi. 10.1111/ijd.12480
- By:
- Publication type:
- Article
4
VAGUE LANGUAGE IN THE MMR VACCINE CONTROVERSY: A corpus-assisted discourse analysis of its functional use.
- Published in:
- Lingue e Linguaggi, 2019, v. 29, p. 93, doi. 10.1285/i22390359v29p93
- By:
- Publication type:
- Article
5
Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India.
- Published in:
- Indian Journal of Medical Research, 2014, v. 139, n. 5, p. 773
- By:
- Publication type:
- Article
6
Harms of Hedging in Scientific Discourse: Andrew Wakefield and the Origins of the Autism Vaccine Controversy.
- Published in:
- Technical Communication Quarterly, 2014, v. 23, n. 3, p. 165, doi. 10.1080/10572252.2013.816487
- By:
- Publication type:
- Article
7
Could a fever and rash after the measles, mumps and rubella vaccination indicate wild-type measles?
- Published in:
- Acta Paediatrica, 2015, v. 104, n. 5, p. e232, doi. 10.1111/apa.12961
- By:
- Publication type:
- Article
8
A timeline of the Wakefield retraction.
- Published in:
- Nature Medicine, 2010, v. 16, n. 3, p. 248, doi. 10.1038/nm0310-248b
- Publication type:
- Article
9
Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2015, v. 4, n. 4, p. 339, doi. 10.1093/jpids/piu081
- By:
- Publication type:
- Article
10
Measles-Mumps-Rubella-Varicella Combination Vaccine (ProQuad): A Guide to Its Use in Children in the EU.
- Published in:
- Pediatric Drugs, 2015, v. 17, n. 2, p. 167, doi. 10.1007/s40272-015-0123-7
- By:
- Publication type:
- Article
11
THE IMPACT OF A "CHOSEN" PHYSICIAN ON IMMUNIZATION COVERAGE WITH MMR VACCINE.
- Published in:
- Acta Medica Medianae, 2015, v. 54, n. 2, p. 56, doi. 10.5633/amm.2015.0210
- By:
- Publication type:
- Article
12
GMC discredits research linking MMR to autism.
- Published in:
- Community Practitioner, 2010, v. 83, n. 3, p. 5
- Publication type:
- Article
13
Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139680
- By:
- Publication type:
- Article
14
Indian Academy of Pediatrics (IAP) Recommended Immunization Schedule for Children Aged 0 through 18 years -- India, 2014 and Updates on Immunization.
- Published in:
- Indian Pediatrics, 2014, v. 51, n. 10, p. 785, doi. 10.1007/s13312-014-0504-y
- By:
- Publication type:
- Article
15
Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 15, p. 1534, doi. 10.1001/jama.2015.3077
- By:
- Publication type:
- Article
16
Live Vaccine Against Measles, Mumps, and Rubella and the Risk of Hospital Admissions for Nontargeted Infections.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 8, p. 826, doi. 10.1001/jama.2014.470
- By:
- Publication type:
- Article
17
Risk of febrile seizures after first dose of measles--mumps-- rubella--varicella vaccine: a population-based cohort study.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2014, v. 186, n. 11, p. 824, doi. 10.1503/cmaj.140078
- By:
- Publication type:
- Article